Article Correctness Is Author's Responsibility: NDA for First-of-Its-Kind Opioid Analgesic Submitted to FDA

The article below may contain offensive and/or incorrect content.

A NDA has been submitted for NKTR-181, an opioid analgesic molecule designed to provide pain relief with fewer CNS-mediated side effects.